Has Kaylea Reeves received payments from drug or device companies?

Yes. Drug and device makers reported $2,199 in general payments to Kaylea Reeves across 86 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kaylea Reeves did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kaylea Reeves come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kaylea Reeves

Adult Health · Flossmoor, ILNPI 1881101350

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,198 and has fallen 82.6% since, to $208 in 2025.

$2,199in general payments, 2019–2025

Across 86 payments — averaging $25.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$352
Boston Scientific$281
Teleflex LLC$212
Astellas Pharma US Inc$183
Axonics, Inc.$148
AbbVie$142
plus $880 from 14 others

What the payments were for

Food & beverage$2,199100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	4	$352
Boston Scientific	10	$281
Teleflex LLC	4	$212
Astellas Pharma US Inc	12	$183
Axonics, Inc.	7	$148
AbbVie(2 entities)	7	$142
Myovant Sciences Inc.	6	$131
Sanofi-aventis U.S. LLC	1	$125
Urovant Sciences Inc	6	$100
Endo Pharmaceuticals Inc.	5	$87
Coloplast	4	$70
Tolmar Pharmaceuticals, Inc.	3	$63
Antares Pharma, Inc.	4	$56
Clarus Therapeutics Inc.	3	$44
Convatec Inc.	2	$42
Procept Biorobotics Corporation	2	$40
Blue Earth Diagnostics	2	$38
Johnson & Johnson	2	$38
Progenics Pharmaceuticals, Inc.	1	$26
Tempus AI, Inc	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,199 in reported general payments places this provider in the 85th percentile of 553 adult health providers in Illinois.

See all adult health providers in Illinois →

Other adult health in Flossmoor

Kimberly KearnsHoffman Estates$531K
Leslie ForresterArlington Heights$97K
Colleen FolkersChicago$86K
Matthew BurkeChicago$44K
Jacklyn GideonChicago$38K
Jennifer GreenfieldChicago$35K
Tammy PomaChicago$32K
Tammy BrownNorth Chicago$31K
Eileen SchedelAurora$21K
Julia BuesserGurnee$18K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →